The cardiovascular risk of JAK inhibitors in treating rheumatic diseases.

MLA

Kwan, Alexander, et al. “The Cardiovascular Risk of JAK Inhibitors in Treating Rheumatic Diseases.” International Journal of Rheumatic Diseases, vol. 27, no. 8, Aug. 2024, pp. 1–12. EBSCOhost, https://doi.org/10.1111/1756-185X.15308.

APA

Kwan, A., Ingrid, E., Jiang, M., & Lim, K. K. T. (2024). The cardiovascular risk of JAK inhibitors in treating rheumatic diseases. International Journal of Rheumatic Diseases, 27(8), 1–12. https://doi.org/10.1111/1756-185X.15308

Chicago

Kwan, Alexander, Elvina Ingrid, Matthew Jiang, and Keith K. T. Lim. 2024. “The Cardiovascular Risk of JAK Inhibitors in Treating Rheumatic Diseases.” International Journal of Rheumatic Diseases 27 (8): 1–12. doi:10.1111/1756-185X.15308.